Actively Recruiting
Inspire Singapore Study
Led by Inspire Medical Systems, Inc. · Updated on 2024-08-19
44
Participants Needed
2
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, multicenter, open-label study designed to confirm device performance of Inspire system in Singapore.
CONDITIONS
Official Title
Inspire Singapore Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of moderate to severe obstructive sleep apnea with an apnea-hypopnea index (AHI) between 15 and 65
- Failure of, or intolerance to, continuous positive airway pressure (CPAP) therapy
- Age 21 years or older
You will not qualify if you...
- Central and mixed apneas make up more than 25% of total apnea-hypopnea index
- Presence of complete concentric collapse (CCC) of the airway
- Compromised neurological control of the upper airway
- Other eligibility criteria may apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
National University Hospital
Singapore, Singapore
Actively Recruiting
2
Singapore General Hospital
Singapore, Singapore
Actively Recruiting
Research Team
G
Gwen Gimmestad
CONTACT
M
Mike Swierzewski
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here